Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 14, 2005; 11(10): 1529-1531
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1529
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1529
Table 1 Clinical findings of 128 patients with liver disease.
| Number of cases | Sex (M:F) | Mean of age (yr) | Positive rate of HBsAg, n (%) | Positive rate of anti-HCV, n (%) | |
| Alcoholic liver injury | 6 | 5:01 | 57±6 | 0 | 0 |
| Chronic hepatitis | 67 | 45:22:00 | 52±13 | 11 (16.4) | 49 (73.1) |
| Liver cirrhosis | 45 | 29:16:00 | 56±10 | 8 (17.8) | 26 (57.8) |
| Hepatocellular carcinoma | 10 | 9:1 | 66±7 | 3 (30.0) | 5 (50.0) |
- Citation: Tameda M, Shiraki K, Ooi K, Takase K, Kosaka Y, Nobori T, Tameda Y. Aspartate aminotransferase-immunoglobulin complexes in patients with chronic liver disease. World J Gastroenterol 2005; 11(10): 1529-1531
- URL: https://www.wjgnet.com/1007-9327/full/v11/i10/1529.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i10.1529